The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
235-256
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris
Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Journal:
Current Genomics
Volume:
5
Page:
309-325
Author(s):
Raphael Saffroy, Franck Chiappini, Brigitte Debuire and Antoinette Lemoine
Potential for Predicting Toxicity and Response of Fluoropyrimidines in Patients
Journal:
Current Drug Targets
Volume:
5
Page:
383-388
Author(s):
James F. Eliason and Attila Megyeri
New Molecules and Strategies in the Field of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
247-262
Author(s):
Marchini S., D'Incalci M. and Broggini M.
Current Status of Delivery Systems to Improve Target Efficacy of Oligonu-cleotides
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
785-796
Author(s):
Yoko Shoji and Hideki Nakashima
Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Journal:
Current Gene Therapy
Volume:
4
Page:
53-63
Author(s):
Hideshi Ishii, Andrea Vecchione, Louise Y.Y. Fong, Nicola Zanesi, Francesco Trapasso, Yusuke Furukawa, Raffaele Baffa, Kay Huebner and Carlo M. Croce
The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
111-124
Author(s):
Patrick Onyango
Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
125-146
Author(s):
Johann Hofmann
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
71-81
Author(s):
Joseph Ciccolini, Alexandre Evrard and Pierre Cuq
Recent Anticancer Cytotoxic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
93-121
Author(s):
Paolo Cozzi, Nicola Mongelli and Antonino Suarato